Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17 to treat Huntington’s disease to be presented at the 16th Annual Huntington’s Disease Therapeutics Conference
Monoclonal antibody C6-17 designed to target mutant huntingtin protein (mtHTT) and to reduce spread of…
Liontown Selects InEight Document to Support Mining Project Information Management